Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Org 31710

Known as: Org-31710 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
SummaryAntiprogestins have been largely utilized in reproductive medicine, yet their repositioning for oncologic use is rapidly… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2009
2009
Progesterone (P4) antagonizes estradiol (E2) in synaptic remodeling in the hippocampus during the rat estrous cycle. To further… Expand
Is this relevant?
Review
2005
Review
2005
ORG 31710 and ORG 33628 were used in studies aiming to control vaginal bleeding in combination with progestagen-only… Expand
Is this relevant?
2004
2004
OBJECTIVE To investigate the effect of the anti-P Org 31710 on human blastocyst attachment to cultured endometrial epithelial… Expand
Is this relevant?
2001
2001
OBJECTIVE To investigate if progesterone receptor (PR)-mediated effects are involved in regulating the susceptibility to… Expand
Is this relevant?
2000
2000
Abstract Progesterone (P) is one of several local mediators in the ovulatory cascade in the rat. The precise mechanisms of action… Expand
Is this relevant?
2000
2000
Org 31710 and Org 33628 are two highly selective progesterone receptor modulators (PRMs) with respect to their anti… Expand
Is this relevant?
2000
2000
Endocrine and ultrasound effects were studied of an intermittent (every 28 days) oral administration of 150 mg of the anti… Expand
  • table I
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
1999
Highly Cited
1999
To investigate ovulation, an in vitro model with cultured mouse follicles was developed and compared with an in vivo ovulation… Expand
Is this relevant?
1994
1994
Org 31710 and Org 31806 are new antiprogestagens. These compounds were tested for their binding affinity to various steroid… Expand
Is this relevant?